Paris-headquartered life-sciences-focused venture capital investor Sofinnova Partners has held a final close for its flagship early-stage venture healthcare fund Sofinnova Capital IX on €333m.
De Scorbiac was responsible for the Accenture Venture fund's activities in Europe
GP sells the Dutch employment agency to its CEO, ending its three-years ownership
Financing for the acquisition was provided by Santander Corporate and Commercial Banking
Sussex Place Ventures, Contour Ventures, Partnership Fund and Outrun Ventures also take part